BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 3978620)

  • 1. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR; Murphy LC; Hall RE; Sutherland RL
    Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
    Reddel RR; Sutherland RL
    Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
    Koga M; Musgrove EA; Sutherland RL
    Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.
    Reddel RR; Alexander IE; Koga M; Shine J; Sutherland RL
    Cancer Res; 1988 Aug; 48(15):4340-7. PubMed ID: 3390830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen-resistant human breast cancer cell growth: inhibition by thioridazine, pimozide and the calmodulin antagonist, W-13.
    Strobl JS; Peterson VA
    J Pharmacol Exp Ther; 1992 Oct; 263(1):186-93. PubMed ID: 1403784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro.
    Reddel RR; Murphy LC; Sutherland RL
    Cancer Res; 1983 Oct; 43(10):4618-24. PubMed ID: 6883318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
    Osborne CK; Boldt DH; Estrada P
    Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture.
    Jain PT; Pento JT; Magarian RA
    Anticancer Res; 1992; 12(3):585-90. PubMed ID: 1622114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].
    Bachmann-Moisson N; Barberi-Heyob M; Merlin JL; Ledrich ML; Batt AM; Guillemin F
    Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen.
    Reddel RR; Murphy LC; Sutherland RL
    Cancer Res; 1984 Jun; 44(6):2398-405. PubMed ID: 6722780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
    Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL
    Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells.
    Dubik D; Dembinski TC; Shiu RP
    Cancer Res; 1987 Dec; 47(24 Pt 1):6517-21. PubMed ID: 3677090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line MCF-7.
    Lykkesfeldt AE; Larsen JK; Christensen IJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S83-90. PubMed ID: 3742066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tamoxifen and estradiol on the growth of human breast cancer cells in vitro.
    Arafah BM; Griffin P; Gordon NH; Pearson OH
    Cancer Res; 1986 Jul; 46(7):3268-72. PubMed ID: 3708561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K; Su J; Trovitch PB
    J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ; Zhu BT
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
    ter Haar E; Day BW
    Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.